Bufuralol
From Wikipedia, the free encyclopedia
| Bufuralol | |
|---|---|
 |
|
|
2-(tert-Butylamino)-1-(7-ethyl-1-benzofuran-2-yl)ethanol |
|
| Identifiers | |
| CAS number | 54340-62-4  |
| PubChem | 71733 |
| ChemSpider | 64777 |
| UNII | 891H89GFT4 |
| ChEMBL | CHEMBL296035 |
| Jmol-3D images | Image 1 |
|
|
|
|
| Properties | |
| Molecular formula | C16H23NO2 |
| Molar mass | 261.36 g mol−1 |
| Except where noted otherwise, data are given for materials in their standard state (at 25 °C, 100 kPa) | |
| Infobox references |
Bufuralol is a potent beta-adrenoceptor antagonist with partial agonist activity.[1] It is metabolized by CYP2D6.[2]
[edit] References
- ^ Pringle, TH; Francis, RJ; East, PB; Shanks, RG (1986). "Pharmacodynamic and pharmacokinetic studies on bufuralol in man"British journal of clinical pharmacology 22 (5): 527–34. PMC 1401192. PMID 2878678. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=1401192.
- ^ Flockhart DA (2007). "Drug Interactions: Cytochrome P450 Drug Interaction Table". Indiana University School of Medicine. http://medicine.iupui.edu/flockhart/table.htm. Retrieved on July 2011
 |
This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it. |
